Zhang Michael, Chen Yi-Ren, Chang Steven D, Veeravagu Anand
Department of Neurosurgery, Stanford University, Palo Alto, California.
Neurosurg Focus. 2017 Jan;42(1):E13. doi: 10.3171/2016.9.FOCUS16372.
OBJECTIVE Symptomatic vertebral hemangiomas (SVHs) are a very rare pathology that can present with persistent pain or neurological deficits that warrant surgical intervention. Given the relative rarity and difficulty in assessment, the authors sought to present a dedicated series of SVHs treated using stereotactic radiosurgery (SRS) to provide insight into clinical decision making. METHODS A retrospective review of a single institution's experience with hypofractionated radiosurgery for SVH from 2004 to 2011 was conducted to determine the clinical and radiographic outcomes following SRS treatment. The authors report and analyze the treatment course of 5 patients with 7 lesions, 2 of which were treated primarily by SRS. RESULTS Of the 5 patients studied, 4 presented with a chief complaint of pain refractory to conservative measures. Three patients reported dysesthesias, and 2 reported upper-extremity weakness. Following radiosurgery, 4 of 5 patients exhibited improvement in their primary symptoms (3 for pain and 1 for weakness), achieving a clinical response after a mean period of 1 year. In 2 cases there was 20%-40% reduction in lesion size in the most responsive dimension as noted on images. All treatments were well tolerated. CONCLUSIONS SRS for SVH is a safe and feasible treatment strategy, comparable to prior radiotherapy studies, and in select cases may successfully confer delayed decompressive effects. Additional investigation will determine future patient selection and how conformal SRS treatment can best be administered.
目的 有症状的椎体血管瘤(SVH)是一种非常罕见的病理情况,可表现为持续疼痛或神经功能缺损,需要手术干预。鉴于其相对罕见且评估困难,作者试图展示一系列使用立体定向放射外科(SRS)治疗的SVH病例,以深入了解临床决策。方法 对一家机构2004年至2011年期间使用分割放射外科治疗SVH的经验进行回顾性研究,以确定SRS治疗后的临床和影像学结果。作者报告并分析了5例患者共7个病灶的治疗过程,其中2个病灶主要采用SRS治疗。结果 在研究的5例患者中,4例主要症状为保守治疗无效的疼痛。3例患者报告感觉异常,2例报告上肢无力。放射外科治疗后,5例患者中有4例的主要症状有所改善(3例疼痛改善,1例无力改善),平均1年后获得临床缓解。在2例患者中,影像学显示最敏感维度的病灶大小缩小了20%-40%。所有治疗耐受性良好。结论 SRS治疗SVH是一种安全可行的治疗策略,与先前的放射治疗研究结果相当,在某些情况下可能成功产生延迟减压效果。进一步的研究将确定未来的患者选择以及如何最佳地实施适形SRS治疗。